Israel: Fourth Subject Treated

On June 15, 2014, the fourth subject was treated in our ongoing Israeli study of MDMA-assisted psychotherapy for 10 subjects with chronic, treatment-resistant PTSD. The first subject was treated in April …

Israel: Fourth Subject Enrolled

On May 13, 2014, the fourth subject was enrolled in our ongoing Israeli study of MDMA-assisted psychotherapy for 10 subjects with chronic, treatment-resistant PTSD. The  subject prematurely reported last …

Israel: Site Monitoring Visit Completed

On January 7, 2014, MAPS Clinical Research Associate Mimi Peleg completed the regularly scheduled site monitoring visit for our ongoing Israeli study of MDMA-assisted psychotherapy for PTSD. The study …

Israel: Third Subject Begins Treatment

On November 27, 2013, the third subject began treatment in our ongoing Israeli study of MDMA-assisted psychotherapy for 10 subjects with chronic, treatment-resistant PTSD. Goals for this study include …

Israel: Second Subject Enrolled

On May 29, 2013, the second subject was enrolled in our ongoing Israeli study of treating PTSD with MDMA-assisted psychotherapy. This study, led by Clinical Investigator Moshe Kotler, M.D., at Beer Yaakov …

Israel: First Subject Enrolled

On February 12, 2013, the first subject was enrolled in our new Israeli study of MDMA-assisted psychotherapy for PTSD. This study will enroll 10 subjects with chronic, treatment-resistant PTSD, some of …

Israel: First Subject Completes In-Person Screening

On January 17, 2013, the first subject completed in-person screening for our new Israeli study of MDMA-assisted psychotherapy for PTSD, led by Principal Investigator Moshe Kotler, M.D., and monitored by …